A5073275543- Lung Cancer Treatments and Mutations
- Venous Thromboembolism Diagnosis and Management
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- Glioma Diagnosis and Treatment
- Cancer Diagnosis and Treatment
- Lung Cancer Research Studies
- Gastric Cancer Management and Outcomes
- Dysphagia Assessment and Management
- Neuroblastoma Research and Treatments
- Hepatitis C virus research
- Neuroendocrine Tumor Research Advances
- Central Venous Catheters and Hemodialysis
- Asthma and respiratory diseases
- Molecular Biology Techniques and Applications
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Genomics and Diagnostics
- Cerebrovascular and Carotid Artery Diseases
- Tracheal and airway disorders
- Respiratory and Cough-Related Research
- Cancer Treatment and Pharmacology
- Prostate Cancer Treatment and Research
- Head and Neck Cancer Studies
- Liver Disease Diagnosis and Treatment
- Oral health in cancer treatment
Clalit Health Services
2025
Spanish Society of Hematology and Hemotherapy
2023-2024
Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone" di Palermo
2023
Hospital Universitario 12 De Octubre
2023
Complejo Hospitalario Universitario de Albacete
2011-2022
Hospital Clínico Universitario de Valencia
2020-2022
University of Palermo
2017-2021
Hospital Rio Carrion
2020
Hospital Obispo Polanco
2015-2019
Hospital General Universitario de Albacete
2015
The association between acromegaly and cancer had been assessed mainly in population studies with inconsistent results. objective of this study was to investigate the risk a large cohort patients compared matched controls. comprehensive computerized database largest healthcare provider organization Israel searched for diagnosed 2000-2021. All diagnoses were qualitatively validated. Patients individually 1:5 control group age, sex, socioeconomic status. Clinical outcome data collected from...
Viviana Perez, APRN, FNP-C, of Moffitt Cancer Center, considers real-world outcomes presented at the 2024 ASH Annual Meeting momelotinib, a JAK1/JAK2/ACVR1 inhibitor that has shown promise in treating myelofibrosis patients with anemia.
Background. We compared the prognostic value of liver biopsy (LB) and FIB-4 index in patients with human immunodeficiency virus (HIV)/hepatitis C (HCV) coinfection.
Pancreatic carcinoma is one of the tumors associated with a higher risk for thromboembolic events, incidence rates ranging from 5% to 41% in previous retrospective series.We conducted study eleven Spanish hospitals that included 666 patients diagnosed pancreatic (any stage) between 2008 and 2011 treated chemotherapy. The main objective was evaluate venous events (VTE) this population, as well potential factors thrombosis. impact VTE on mortality also assessed.With median follow-up 9.3...
Both venous and arterial thrombotic events (VTE/AT) can be associated with Immune Checkpoint Inhibitors (ICI). However, there is a paucity of information apropos patients in routine clinical practice.
The utility of many molecules as tumor markers in melanoma has been investigated with different results. aims this study was to compare the value tyrosinase mRNA by reverse transcription polymerase chain reaction (RT-PCR) peripheral blood and serum S-100 protein patients at stages disease.We have studied 90 samples corresponding that had diagnosed melanoma. clinical staging time sampling performed according American Join Committee on Cancer guidelines. measured enzyme-linked immunosorbent...
Abstract Objective To evaluate the impact of hepatitis C virus (HCV) elimination via interferon (IFN)-based therapy on gene expression profiles related to immune system in HIV/HCV-coinfected patients. Methods We conducted a prospective study 28 patients receiving IFN-based at baseline (HIV/HCV-b) and week 24 after sustained virological response (HIV/HCV-f). Twenty-seven HIV-monoinfected (HIV-mono) were included as control. RNA-seq analysis was performed peripheral blood mononuclear cells...
Both venous and arterial thrombotic events (VTE/AT) can be associated with immune checkpoint inhibitors (ICI). However, there is a paucity of information apropos patients in routine clinical practice.Retrospective, multicenter study promoted by the Thrombosis Cancer Section Spanish Society Medical Oncology (SEOM). Individuals kidney or bladder cancer who initiated ICI between 01/01/2015 12/31/2020 were recruited. Minimum follow-up was 6 months (except cases demise). The primary objective to...
Relapse after chemotherapy treatment depends on the cancer initiating cells (CICs). PEDF (Pigmented Epithelium Derived Factor) is an anti-angiogenic, neurotrophic and self-renewal regulator molecule, also involved in CICs biology. Acute chronic exposition of colon cell lines to CT/CTE PEDF-derived peptides decreased drug-resistance conventional colorectal treatments, such as oxaliplatin or irinotecan. We confirmed a reduction irinotecan IC50 doses for all tested tumour lines. After xenograft...
Little is known about the effects of eradication hepatitis C virus (HCV) on bone mineral density (BMD) and biomarkers remodeling in human immunodeficiency (HIV)/HCV-coinfected patients.We prospectively assessed standardized BMD (sBMD) at lumbar spine femoral neck, World Health Organization categories both sites, plasma concentrations soluble receptor activator NF-κβ ligand (sRANKL), osteoprotegerin (OPG) baseline (the date initiation anti-HCV therapy) 96 weeks.A total 238 patients were...
e20658 Background: Splanchnic vein thrombosis (SVT) is a common complication in exocrine pancreatic cancer (EPC) receiving chemotherapy ambulatory setting. However it´s true incidence and prognosis remains uncertain. So far, only few studies have addressed the outcome of patients with EPC SVT. Methods: We performed retrospective chart review to determine SVT attended ten hospitals Cancer & Thrombosis Working Group Spanish Society Medical Oncology (SEOM). 626 consecutive who were diagnosed...
The advances of recent decades in the diagnosis and treatment cancer have managed to increase survival, but this has produced an neurological complications. These complications can be caused by its sometimes first manifestation disease. Some these are potentially reversible so that early proper improve symptoms quality life patients. In article we will review major patients also do a diagnostic therapeutic orientation.
e13056 Background: VTE is a common complication in HGG; however, it´s incidence remain uncertain. KS the only validated predictive model to gauge cancer patient´s risk for developing VTE. Methods: The aim of this study analyze and ambulatory patients (pts) with HGG receiving chemotherapy. We performed retrospective review 10 hospitals Cancer Thrombosis Working Group Spanish Society Medical Oncology (SEOM). A total 469 consecutive from January 2008 through December 2011 were included...
e15187 Background: VTE is a common complication in exocrine pancreatic cancer (EPC), however it´s true incidence remains uncertain. Khorana’s score the only validated predictive model to gauge patients’ risk for developing VTE. Methods: The aim of this study analyze symptomatic and incidental Khorana ambulatory patients (pts) with EPC receiving chemotherapy. We performed retrospective review nine hospitals Cancer&Thrombosis Working Group-Spanish Society Medical Oncology (SEOM). A total 571...